Innoveren Scientific Inc.

Innoveren Scientific Inc. operates as a life science and biotech incubator focused on developing next-generation cellular therapies and medical devices targeting unmet needs in regenerative medicine and chronic diseases. Its commercialized products include SkinDisc™, an active cellular matrix for wound healing that achieves rapid tissue growth in four to nine weeks from a single application; and BreatheEasy™, an autologous IV infusion device cleared via the FDA’s De Novo pathway to help patients with COPD and related conditions. The company also has early-stage immunotherapy programs targeting ovarian cancer, pancreatic cancer, and mesothelioma. It was formerly known as H-CYTE until July 2023.[1][2][5]